PIK3CA and colorectal carcinoma: An integrated model—combining physical activity, dietary modulation (e.g., Mediterranean diet), and low-dose aspirin in selected patients—emerges as a promising strategy to shape the gut microbiota, reduce inflammation, and enhance anti-tumor immune surveillance, especially in biomarker-defined populations (e.g., PIK3CA-mutant CRC).